当前位置:首页 - 行情中心 - 蓝宇股份(301585) - 财务分析 - 利润表

蓝宇股份

(301585)

  

流通市值:9.00亿  总市值:36.02亿
流通股本:2600.00万   总股本:1.04亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入210,802,498.8795,041,860.84478,460,736.42357,979,324.66
  营业收入210,802,498.8795,041,860.84478,460,736.42357,979,324.66
二、营业总成本181,739,752.3584,163,354.82364,414,533.63266,042,567.69
  营业成本144,146,647.0764,752,569.4299,835,496.08220,475,892.47
  税金及附加2,025,758.62989,651.684,751,838.343,495,850.94
  销售费用10,946,634.185,404,483.1617,314,724.811,400,718.12
  管理费用14,575,226.528,266,617.8924,423,247.2215,738,943.24
  研发费用10,801,615.345,182,209.9922,144,058.0715,617,182.56
  财务费用-756,129.38-432,177.3-4,054,830.88-686,019.64
  其中:利息费用--775,847.17669,305.5
  其中:利息收入--2,718,084.651,750,384.91
三、其他经营收益
  加:公允价值变动收益298,365.8673,830.82867,219.95654,692.4
  加:投资收益1,757,996.59422,595.9238,873.42110,785.34
  资产处置收益173,983.93171,099.1318,039.163,039.15
  资产减值损失(新)-176,575.14-58,946.9-967,291.09-444,825.01
  信用减值损失(新)-16,827.053,832,038.95-3,466,491.68-2,422,640.59
  其他收益2,286,528.7525,023.285,735,085.523,515,874.9
四、营业利润33,386,219.415,944,147.2116,471,638.0793,353,683.16
  加:营业外收入158,363.7282,376.07114,553.63112,145.26
  减:营业外支出394,969.41333,215.66115,322.28103,622.26
五、利润总额33,149,613.7115,693,307.61116,470,869.4293,362,206.16
  减:所得税费用4,603,704.622,323,459.0515,962,325.2611,263,756.22
六、净利润28,545,909.0913,369,848.56100,508,544.1682,098,449.94
(一)按经营持续性分类
  持续经营净利润28,545,909.0913,369,848.56100,508,544.1682,098,449.94
(二)按所有权归属分类
  归属于母公司股东的净利润28,662,914.3713,375,111.51100,508,544.1682,098,449.94
  少数股东损益-117,005.28-5,262.95--
  扣除非经常损益后的净利润26,966,885.0212,509,982.495,672,555.6979,025,312.02
七、每股收益
  (一)基本每股收益0.280.171.681.37
  (二)稀释每股收益0.280.161.681.37
八、其他综合收益-41,827.53-11,563.15126.9-
  归属于母公司股东的其他综合收益-41,827.53-11,563.15126.9-
九、综合收益总额28,504,081.5613,358,285.41100,508,671.0682,098,449.94
  归属于母公司股东的综合收益总额28,621,086.8413,363,548.36100,508,671.0682,098,449.94
  归属于少数股东的综合收益总额-117,005.28-5,262.95--
公告日期2025-08-292025-04-182025-04-182024-11-28
审计意见(境内)标准无保留意见
TOP↑